Reaction
Basdai Score Increased reporting signals
As of the last recalculation, Basdai Score Increased appears in 61 FAERS reports alongside 2 co-occurring drug terms. The strongest observed disproportionality signal is CERTOLIZUMAB PEGOL (PRR 390.4).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Certolizumab Pegol | 42 | 390.4 | 390.5 |
| Bimekizumab | 9 | 169.0 | 169.0 |